Homo sapiens (human)

Summary
Taxonomy ID
9606
PubChem Taxonomy
9606
Displaying entries 4451 - 4475 of 18496 in total
UniProt ID Protein Name Gene Symbol No. of Glycosylation Sites No. of GlyTouCan IDs ▲ Disease Ontology
P30872 Somatostatin receptor type 1
  • SSTR1
3 0
A0A3G4R8Q2 MHC class I antigen
  • HLA-C
1 0
Q9GZU5 Nyctalopin
  • NYX
  • CLRP
6 0
I6NWI6 MHC class I antigen (Fragment)
  • HLA-B
1 0
J3QQQ0 Phospholipase A1
  • LIPG
1 0
H9C5I9 MHC class I antigen (Fragment)
  • HLA-C
1 0
A0A186VN37 MHC class I antigen (Fragment)
  • HLA-B
1 0
Q8NGH6 Putative olfactory receptor 52L2
  • OR52L2P
  • OR52L2
1 0
Q9UKR3 Kallikrein-13
  • KLK13
  • KLKL4
2 0
D3U3Z2 MHC class I antigen (Fragment)
  • HLA-B
1 0
E7EPS8 protein-tyrosine-phosphatase
  • PTPRM
1 0
A0A3B3IRW1 Tissue factor pathway inhibitor 2 (Fragment)
  • TFPI2
1 0
A0A0G2R0W3 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8WD96 Cathepsin D
  • CTSD
1 0
F6IQK2 MHC class I antigen (Fragment)
  • HLA-C
1 0
A0A2S0SYU6 MHC class I antigen
  • HLA-C
1 0
E9PL32 Cathepsin B (Fragment)
  • CTSB
1 0
A0A0A7C4P7 MHC class I antigen (Fragment)
  • HLA-C
1 0
F6IQL5 MHC class I antigen (Fragment)
  • HLA-C
1 0
Q9NPB9 Atypical chemokine receptor 4
  • ACKR4
  • CCBP2
  • CCR11
  • CCRL1
  • VSHK1
2 0
V9HWF5 Peptidyl-prolyl cis-trans isomerase
  • HEL-S-69p
1 0
B7Z550 Complement component C8 beta chain
  • C8B
1 0
Q9P1P4 Putative trace amine-associated receptor 3
  • TAAR3P
  • GPR57
  • TAAR3
1 0
A0A0A7C8Q7 MHC class I antigen (Fragment)
  • HLA-B
1 0
Q8NET5 NFAT activation molecule 1
  • NFAM1
  • CNAIP
1 0

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024